Strategic Wealth Management Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.38M Sell
8,363
-553
-6% -$91.6K 0.5% 26
2021
Q1
$1.47M Sell
8,916
-736
-8% -$119K 0.56% 28
2020
Q4
$1.52M Buy
9,652
+521
+6% +$76.9K 0.66% 24
2020
Q3
$1.36M Buy
9,131
+320
+4% +$47.4K 0.66% 26
2020
Q2
$1.24M Buy
8,811
+602
+7% +$87.7K 0.73% 22
2020
Q1
$1.08M Sell
8,209
-186
-2% -$26.4K 0.8% 22
2019
Q4
$1.23M Buy
8,395
+567
+7% +$76.9K 0.79% 21
2019
Q3
$1.01M Buy
7,828
+63
+0.8% +$8.3K 0.73% 26
2019
Q2
$1.08M Sell
7,765
-163
-2% -$22.6K 0.82% 24
2019
Q1
$1.11M Buy
7,928
+156
+2% +$20.9K 0.91% 20
2018
Q4
$1M Buy
+7,772
New +$1.08M 0.96% 20

Other funds holding JNJ

Strategic Wealth Management Group's JNJ Position: Q2 2021 in Review

Strategic Wealth Management Group reduced its Johnson & Johnson (JNJ) stake by 6.2% in Q2 2021, selling an estimated $91.6K and leaving 8,363 shares worth $1.38M. The position accounts for 0.5% of the portfolio, ranked #26.

Strategic Wealth Management Group first reported a position in JNJ in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.52M in Q4 2020. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • Strategic Wealth Management Group held 8,363 shares of Johnson & Johnson worth $1.38M as of Q2 2021.
  • Strategic Wealth Management Group sold 553 Johnson & Johnson shares in Q2 2021, an estimated $91.6K.
  • Johnson & Johnson made up 0.5% of Strategic Wealth Management Group's portfolio in Q2 2021, its #26 holding.
  • Strategic Wealth Management Group first reported a position in Johnson & Johnson in Q4 2018 and has held it in 11 quarters since.
  • Strategic Wealth Management Group's Johnson & Johnson position peaked at $1.52M in Q4 2020.
  • 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.